India · Delayed Price · Currency is INR Johnson Pharmacare Statistics
Total Valuation
BOM:532154 has a market cap or net worth of INR 286.00 million. The enterprise value is 296.74 million.
| Market Cap | 286.00M |
| Enterprise Value | 296.74M |
Important Dates
The next estimated earnings date is Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:532154 has 550.00 million shares outstanding.
| Current Share Class | 550.00M |
| Shares Outstanding | 550.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 519.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -49.47 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.98, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.98 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.06% and return on invested capital (ROIC) is -1.64%.
| Return on Equity (ROE) | -1.06% |
| Return on Assets (ROA) | -0.99% |
| Return on Invested Capital (ROIC) | -1.64% |
| Return on Capital Employed (ROCE) | -1.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.50M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.52% in the last 52 weeks. The beta is -0.97, so BOM:532154's price volatility has been lower than the market average.
| Beta (5Y) | -0.97 |
| 52-Week Price Change | -49.52% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 31.55 |
| Average Volume (20 Days) | 785,685 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.33M |
| Pretax Income | -6.00M |
| Net Income | -6.00M |
| EBITDA | n/a |
| EBIT | -9.33M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 311,000 in cash and 11.05 million in debt, with a net cash position of -10.74 million or -0.02 per share.
| Cash & Cash Equivalents | 311,000 |
| Total Debt | 11.05M |
| Net Cash | -10.74M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 561.12M |
| Book Value Per Share | n/a |
| Working Capital | 149.26M |
Cash Flow
| Operating Cash Flow | -23.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:532154 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |